Back to Search
KAREN RECKAMP, MD
MD
Medical Oncology Physician
NPI: 1649290248IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
A75041(CA)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A75041(CA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 1998
Research & Publications (20)
CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.
PMID 19563666·BMC Cancer·2009
8-other
Chemokines as therapeutic targets in renal cell carcinoma.
PMID 18533798·Expert Rev Anticancer Ther·2008
6-review
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
PMID 18303430·J Thorac Oncol·2008
3-trial
A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.
PMID 16740761·Clin Cancer Res·2006
3-trial
Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium.
PMID 19550249·J Thorac Oncol·2009
8-other
An interdisciplinary care approach for integration of palliative care in lung cancer.
PMID 19073518·Clin Lung Cancer·2008
8-other
The role of targeting mammalian target of rapamycin in lung cancer.
PMID 19073516·Clin Lung Cancer·2008
6-review
Non-small cell lung cancer in the elderly: defining treatment options.
PMID 19027463·Semin Oncol·2008
6-review
NCCN Task Force Report: mTOR inhibition in solid tumors.
PMID 18926092·J Natl Compr Canc Netw·2008
6-review
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
PMID 18316555·Clin Cancer Res·2008
8-other
Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance.
PMID 18303428·J Thorac Oncol·2008
6-review
Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
PMID 17944566·Expert Rev Anticancer Ther·2007
6-review
Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
PMID 17083723·Mol Cancer·2006
7-preclinical
The potential and rationale for COX-2 inhibitors in lung cancer.
PMID 16712449·Anticancer Agents Med Chem·2006
6-review
Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
PMID 16540672·Cancer Res·2006
7-preclinical
Radiofrequency ablation in lung cancer: promising results in safety and efficacy.
PMID 16366374·Oncology (Williston Park)·2005
5-case
The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma.
PMID 16210641·J Immunol·2005
7-preclinical
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.
PMID 16098242·Clin Lung Cancer·2005
6-review
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.
PMID 16034085·J Immunol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E DUARTE RD
DUARTE, CA 91010 - Phone
- (626) 359-8111
Quick Facts
- NPI
- 1649290248
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile